Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Feinglos

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Diabetes Care|May 23, 2018
Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408Adam P Bress, Vasilios Papademetriou, Mark N Feinglos
Diabetes Care|November 6, 2007
Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetesJames D Lane, Mark N Feinglos, Richard S Surwit
Health Services Research|August 21, 2010
Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. ElderlyFrank A Sloan, Mark N Feinglos, Daniel S Grossman
Diabetes Care|October 29, 2008
Offspring of patients with diabetes exhibit a clustering of psychosocial distress and inflammatory and metabolic risk factorsJessica E Shill, Mark N Feinglos, Edward C Suarez
Expert Review of Endocrinology & Metabolism|October 10, 2018
Barriers to care for patients with diabetes in Durham, North Carolina, why are we withholding life-sustaining medications from the patients who need them the most?Susan E Spratt, Mark N Feinglos, Janese M Willis
The Medical Clinics of North America|August 17, 2004
In-hospital management of type 2 diabetes mellitusLillian F Lien, M Angelyn Bethel, Mark N Feinglos
Expert Opinion on Biological Therapy|November 17, 2015
Technosphere insulin: inhaled prandial insulinTracy L Setji, Beatrice D Hong, Mark N Feinglos
Archives of Internal Medicine|May 16, 2007
Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patientsM Angelyn Bethel, Frank A Sloan, Daniel Belsky, et al.
Diabetes Research and Clinical Practice|February 5, 2015
Education, glucose control, and mortality risks among U.S. older adults with diabetesMatthew E Dupre, Mina Silberberg, Janese M Willis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose controlMiriam Amiram, Kelli M Luginbuhl, Xinghai Li, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Diabetes Care|May 23, 2018
Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408Adam P Bress, Vasilios Papademetriou, Mark N Feinglos
Diabetes Care|November 6, 2007
Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetesJames D Lane, Mark N Feinglos, Richard S Surwit
Health Services Research|August 21, 2010
Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. ElderlyFrank A Sloan, Mark N Feinglos, Daniel S Grossman
Diabetes Care|October 29, 2008
Offspring of patients with diabetes exhibit a clustering of psychosocial distress and inflammatory and metabolic risk factorsJessica E Shill, Mark N Feinglos, Edward C Suarez
Expert Review of Endocrinology & Metabolism|October 10, 2018
Barriers to care for patients with diabetes in Durham, North Carolina, why are we withholding life-sustaining medications from the patients who need them the most?Susan E Spratt, Mark N Feinglos, Janese M Willis
The Medical Clinics of North America|August 17, 2004
In-hospital management of type 2 diabetes mellitusLillian F Lien, M Angelyn Bethel, Mark N Feinglos
Expert Opinion on Biological Therapy|November 17, 2015
Technosphere insulin: inhaled prandial insulinTracy L Setji, Beatrice D Hong, Mark N Feinglos
Archives of Internal Medicine|May 16, 2007
Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patientsM Angelyn Bethel, Frank A Sloan, Daniel Belsky, et al.
Diabetes Research and Clinical Practice|February 5, 2015
Education, glucose control, and mortality risks among U.S. older adults with diabetesMatthew E Dupre, Mina Silberberg, Janese M Willis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose controlMiriam Amiram, Kelli M Luginbuhl, Xinghai Li, et al.
Pageof 5